The impact of funding cuts on medical research has become a pressing concern in the scientific community, particularly as it disrupts essential oversight mechanisms that ensure patient safety in studies.Recent federal funding reductions, particularly the halt of over $2 billion in federal research grants at institutions like Harvard, pose a serious threat to the vital processes overseen by Institutional Review Boards (IRBs).